KR102229259B1 - 플럼코트 추출물을 유효성분으로 함유하는 화장료 조성물 - Google Patents
플럼코트 추출물을 유효성분으로 함유하는 화장료 조성물 Download PDFInfo
- Publication number
- KR102229259B1 KR102229259B1 KR1020190022531A KR20190022531A KR102229259B1 KR 102229259 B1 KR102229259 B1 KR 102229259B1 KR 1020190022531 A KR1020190022531 A KR 1020190022531A KR 20190022531 A KR20190022531 A KR 20190022531A KR 102229259 B1 KR102229259 B1 KR 102229259B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- plum
- cosmetic composition
- coat
- skin
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 112
- 239000000203 mixture Substances 0.000 title claims abstract description 70
- 239000002537 cosmetic Substances 0.000 title claims abstract description 53
- 235000010094 aprium Nutrition 0.000 title claims abstract description 6
- 210000002374 sebum Anatomy 0.000 claims abstract description 50
- 230000028327 secretion Effects 0.000 claims abstract description 31
- 239000011148 porous material Substances 0.000 claims abstract description 20
- 230000037303 wrinkles Effects 0.000 claims abstract description 15
- 239000004480 active ingredient Substances 0.000 claims abstract description 12
- 238000009472 formulation Methods 0.000 claims abstract description 12
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 35
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 33
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 32
- 235000001050 hortel pimenta Nutrition 0.000 claims description 32
- 241001512722 Ecklonia cava Species 0.000 claims description 31
- 244000246386 Mentha pulegium Species 0.000 claims description 31
- 238000000034 method Methods 0.000 claims description 19
- 239000003921 oil Substances 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 8
- 239000000839 emulsion Substances 0.000 claims description 7
- 239000006210 lotion Substances 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 5
- 239000006071 cream Substances 0.000 claims description 3
- 239000000499 gel Substances 0.000 claims description 3
- 239000006072 paste Substances 0.000 claims description 3
- 239000000344 soap Substances 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 239000004094 surface-active agent Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 61
- 230000002401 inhibitory effect Effects 0.000 abstract description 42
- 102000029816 Collagenase Human genes 0.000 abstract description 30
- 108060005980 Collagenase Proteins 0.000 abstract description 30
- 229960002424 collagenase Drugs 0.000 abstract description 29
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 abstract description 27
- 102000008186 Collagen Human genes 0.000 abstract description 13
- 108010035532 Collagen Proteins 0.000 abstract description 13
- 229920001436 collagen Polymers 0.000 abstract description 13
- 235000013399 edible fruits Nutrition 0.000 abstract description 9
- 102000004190 Enzymes Human genes 0.000 abstract description 5
- 108090000790 Enzymes Proteins 0.000 abstract description 5
- 229940088598 enzyme Drugs 0.000 abstract description 5
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 description 34
- 244000018633 Prunus armeniaca Species 0.000 description 25
- 235000009827 Prunus armeniaca Nutrition 0.000 description 25
- 238000002360 preparation method Methods 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 238000002474 experimental method Methods 0.000 description 10
- 235000021018 plums Nutrition 0.000 description 10
- 238000000605 extraction Methods 0.000 description 9
- 230000005764 inhibitory process Effects 0.000 description 9
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 8
- 150000004032 porphyrins Chemical class 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- 210000001626 skin fibroblast Anatomy 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- 229960003473 androstanolone Drugs 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 210000001732 sebaceous gland Anatomy 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 4
- 239000007997 Tricine buffer Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 241001474374 Blennius Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 210000001061 forehead Anatomy 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000003757 reverse transcription PCR Methods 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 241001512723 Ecklonia Species 0.000 description 2
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 235000014749 Mentha crispa Nutrition 0.000 description 2
- 241001479543 Mentha x piperita Species 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 241000199919 Phaeophyceae Species 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 229940030275 epigallocatechin gallate Drugs 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- -1 increases Polymers 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000008591 skin barrier function Effects 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229960003604 testosterone Drugs 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 101000831205 Danio rerio Dynein axonemal assembly factor 11 Proteins 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 102100024282 Dynein axonemal assembly factor 11 Human genes 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 229920000855 Fucoidan Polymers 0.000 description 1
- 241001559542 Hippocampus hippocampus Species 0.000 description 1
- 101000831210 Homo sapiens Dynein axonemal assembly factor 11 Proteins 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241001466453 Laminaria Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 235000014435 Mentha Nutrition 0.000 description 1
- 241001072983 Mentha Species 0.000 description 1
- 235000012629 Mentha aquatica Nutrition 0.000 description 1
- 244000173610 Mentha aquatica Species 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 244000078639 Mentha spicata Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 238000010240 RT-PCR analysis Methods 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000007933 dermal patch Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 210000000442 hair follicle cell Anatomy 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000001771 mentha piperita Substances 0.000 description 1
- 239000001220 mentha spicata Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000004378 sebocyte Anatomy 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
도 2는 자두, 살구 및 플럼코트 추출물의 콜라게나아제 활성 억제 효능을 측정한 결과를 나타낸다.
도 3은 플럼코트, 감태, 다시마 및 페퍼민트 복합 추출물의 5α-리덕타아제 활성 억제 효능을 측정한 결과를 나타낸다.
도 4는 플럼코트, 감태, 다시마 및 페퍼민트 복합 추출물의 콜라게나아제 활성 억제 효능을 측정한 결과를 나타낸다.
도 5는 본 발명의 화장료 조성물을 적용하기 전후의 피지분비량을 측정한 결과를 나타낸다.
도 6은 본 발명의 화장료 조성물을 적용하기 전후의 포피린 및 피지의 양을 측정한 결과를 나타낸다.
Claims (9)
- 플럼코트(Plumcot) 추출물을 유효성분으로 포함하는 화장료 조성물로서,
상기 플럼코트 추출물이 감태, 다시마 및 페퍼민트의 혼합물을 더 포함하고,
상기 감태, 다시마 및 페퍼민트의 혼합물이 플럼코트 100중량부에 대하여 80 내지 150중량부로 포함되며,
상기 플럼코트 추출물이 플럼코트 100중량부에 대하여 감태 10 내지 50중량부, 다시마 20 내지 100중량부 및 페퍼민트 10 내지 50중량부를 포함하는 것을 특징으로 하는, 화장료 조성물.
- 제 1 항에 있어서,
상기 플럼코트 추출물을 전체 조성물의 중량을 기준으로 0.0001 내지 10중량% 포함하는 것을 특징으로 하는, 화장료 조성물.
- 삭제
- 삭제
- 삭제
- 제 1 항에 있어서,
용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제 함유 클렌징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이로 구성된 군에서 선택된 제형을 갖는 것을 특징으로 하는, 화장료 조성물.
- 제 1 항, 제 2 항 및 제 6 항 중 어느 한 항에 있어서,
상기 화장료 조성물이 피지 분비 억제용인 것을 특징으로 하는, 화장료 조성물.
- 제 1 항, 제 2 항 및 제 6 항 중 어느 한 항에 있어서,
상기 화장료 조성물이 모공 수축용인 것을 특징으로 하는, 화장료 조성물.
- 제 1 항, 제 2 항 및 제 6 항 중 어느 한 항에 있어서,
상기 화장료 조성물이 피부 주름 개선용인 것을 특징으로 하는, 화장료 조성물.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190022531A KR102229259B1 (ko) | 2019-02-26 | 2019-02-26 | 플럼코트 추출물을 유효성분으로 함유하는 화장료 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190022531A KR102229259B1 (ko) | 2019-02-26 | 2019-02-26 | 플럼코트 추출물을 유효성분으로 함유하는 화장료 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20200104467A KR20200104467A (ko) | 2020-09-04 |
KR102229259B1 true KR102229259B1 (ko) | 2021-03-19 |
Family
ID=72471148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190022531A KR102229259B1 (ko) | 2019-02-26 | 2019-02-26 | 플럼코트 추출물을 유효성분으로 함유하는 화장료 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102229259B1 (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102577747B1 (ko) | 2021-07-12 | 2023-09-12 | 한국해양과학기술원 | 남극 메켈 빙어 추출물 또는 남극 대리석무늬 암치 추출물을 유효성분으로 포함하는 피부 주름개선용 화장료 조성물 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010111745A1 (en) * | 2009-04-02 | 2010-10-07 | Jurlique International Pty Ltd | Compositions and methods for increasing vitamin c uptake into cells and methods for retarding skin ageing, lightening skin and modulating hair colour |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070069625A (ko) * | 2005-12-28 | 2007-07-03 | (주)아모레퍼시픽 | 레티노이드에 의한 피부자극을 완화시키는 페퍼민트추출물을 함유하는 화장료 조성물 |
KR102087123B1 (ko) * | 2017-04-21 | 2020-03-10 | 유씨엘 주식회사 | 펩타이드와 해조류 추출물을 함유하는 나노에멀젼 및 그를 이용한 화장료 조성물 |
-
2019
- 2019-02-26 KR KR1020190022531A patent/KR102229259B1/ko active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010111745A1 (en) * | 2009-04-02 | 2010-10-07 | Jurlique International Pty Ltd | Compositions and methods for increasing vitamin c uptake into cells and methods for retarding skin ageing, lightening skin and modulating hair colour |
Also Published As
Publication number | Publication date |
---|---|
KR20200104467A (ko) | 2020-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2691074A1 (fr) | Composition a base de camellia japonica et polygonum hydropiper pour protection de la peau | |
KR101134716B1 (ko) | Egcg와 장미 추출물을 함유하는 피부 외용제 조성물 | |
KR101319997B1 (ko) | 분홍바늘꽃 및 구슬꽃나무 추출물을 유효성분으로 함유하는 주름개선용 화장료 조성물 | |
JP2015155394A (ja) | 光老化抑制剤 | |
KR101078888B1 (ko) | 조직배양한 에키네시아 부정근 추출물을 포함하는 화장료 조성물 및 이의 제조 방법 | |
KR20150086922A (ko) | 천연발효 솔잎 추출물을 함유하는 피부자극의 완화 및 피부보습용 조성물 | |
KR102214985B1 (ko) | 식물추출물 또는 이의 분획물을 유효성분으로 함유하는 피부 상태 개선용 조성물 | |
KR102229259B1 (ko) | 플럼코트 추출물을 유효성분으로 함유하는 화장료 조성물 | |
KR102278167B1 (ko) | 지질산화 방지, 자외선에 의한 손상 피부 개선 및 피부 진정 효과가 우수한 화장료 조성물 | |
JP7075177B2 (ja) | 化粧料 | |
KR20210018388A (ko) | 식물추출물 또는 이의 분획물을 유효성분으로 함유하는 피부 상태 개선용 조성물 | |
KR20090063381A (ko) | 피부 주름 개선 및 예방용 화장료 조성물 | |
JP2005008548A (ja) | 皮膚外用剤 | |
ES2791066T3 (es) | Composición para reducir los trastornos del envejecimiento de la piel, que comprende un retinaldehído y un extracto de leontopodium alpinum | |
JP6915048B2 (ja) | アルブツス・ウネドの果実抽出物の化粧品としての使用 | |
KR101934976B1 (ko) | 고욤나무 잎 및 울금 추출물의 혼합물을 유효성분으로 함유하는 피부장벽강화용 조성물 | |
KR101220903B1 (ko) | 피부주름개선용 피부외용제 조성물 | |
KR101894747B1 (ko) | 공진단 성분 추출물과 연꽃 추출물을 포함하는 화장료 조성물 | |
KR20090087223A (ko) | 타나까 나무 추출물을 함유하는 모공 수축용 화장료 조성물 | |
KR101557422B1 (ko) | 때죽나무 추출물을 유효성분으로 함유하는 세정 또는 세척제 조성물 및 화장료 조성물 | |
KR20110081514A (ko) | 마디풀 추출물을 함유하는 피부 노화 방지용 화장료 조성물 | |
KR101117560B1 (ko) | 보양액을 포함하는 피부 유연성 개선 화장료 조성물 | |
JP5155543B2 (ja) | エンドセリン−1産生抑制剤、ヘキソサミニダーゼ遊離抑制剤、抗炎症用/美白用皮膚外用剤、エンドセリン−1の産生抑制方法及びヘキソサミニダーゼの遊離抑制方法 | |
KR20160003916A (ko) | 한약재 추출물을 포함하는 미백 또는 안색 개선용 화장료 조성물 | |
KR102419399B1 (ko) | 시카케어 크림 조성물 및 그 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20190226 |
|
PA0201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20200716 Patent event code: PE09021S01D |
|
PG1501 | Laying open of application | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
PE0601 | Decision on rejection of patent |
Patent event date: 20210112 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20200716 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
X091 | Application refused [patent] | ||
AMND | Amendment | ||
PX0901 | Re-examination |
Patent event code: PX09011S01I Patent event date: 20210112 Comment text: Decision to Refuse Application Patent event code: PX09012R01I Patent event date: 20200916 Comment text: Amendment to Specification, etc. |
|
PX0701 | Decision of registration after re-examination |
Patent event date: 20210309 Comment text: Decision to Grant Registration Patent event code: PX07013S01D Patent event date: 20210215 Comment text: Amendment to Specification, etc. Patent event code: PX07012R01I Patent event date: 20210112 Comment text: Decision to Refuse Application Patent event code: PX07011S01I Patent event date: 20200916 Comment text: Amendment to Specification, etc. Patent event code: PX07012R01I |
|
X701 | Decision to grant (after re-examination) | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20210312 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20210312 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20240305 Start annual number: 4 End annual number: 4 |